Unraveling the Association Between Myocardial Infarction of Nonobstructive Coronary Arteries and Antiphospholipid Syndrome.

Autor:	Ramjas V; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Jain A; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Lee RDM; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Fioni F; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Tawfik N; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Sandhu O; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Hamid P; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Aug 08; Vol. 13 (8), pp. e17002. Date of Electronic Publication: 2021 Aug 08 (Print Publication: 2021).
DOI:	10.7759/cureus.17002
Abstrakt:	The term "myocardial infarction with nonobstructive coronary arteries (MINOCA)" refers to a condition characterized by clinical signs and symptoms consistent with acute myocardial infarction (AMI) (as defined by the third universal definition of infarction) and coronary arteries that are angiographically normal or nearly normal. A prominent source of morbidity and mortality in patients with antiphospholipid syndrome (APS) is thrombotic events. To evaluate whether there is a relation between APS and MINOCA in this research, we did an extensive assessment of the existing research in this field. According to the data, APS was associated with microvascular thrombosis, aberrant lipid metabolism, hypertension, and abnormalities of the coagulation cascade, among other conditions. Based on the available data, we discovered evidence that suggests a relationship between MINOCA and APS patients. It is vital to raise awareness of this concern among the general public. Also required is the development and implementation of diagnostic and targeted treatment guidelines for patients with APS and MINOCA. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Ramjas et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu